Abstract
Purpose
Chronic pain is a widespread and debilitating condition, encountered by physicians in a variety of practice settings. Although many pharmacologic and behavioral strategies exist for the management of this condition, treatment is often unsatisfactory. Scrambler Therapy is a novel, non-invasive pain modifying technique that utilizes trans-cutaneous electrical stimulation of pain fibers with the intent of re-organizing maladaptive signaling pathways. This review was conducted to further evaluate what is known regarding the mechanisms and mechanics of Scrambler Therapy and to investigate the preliminary data pertaining to the efficacy of this treatment modality.
Methods
The PubMed/Medline, SCOPUS, EMBASE, and Google Scholar databases were searched for all articles published on Scrambler Therapy prior to November 2015. All case studies and clinical trials were evaluated and reported in a descriptive manner.
Results
To date, 20 reports, of varying scientific quality, have been published regarding this device; all but one small study, published only as an abstract, provided results that appear positive.
Conclusion
The positive findings from preliminary studies with Scrambler Therapy support that this device provides benefit for patients with refractory pain syndromes. Larger, randomized studies are required to further evaluate the efficacy of this approach.
Similar content being viewed by others
References
Simon L (2012) Relieving pain in America: A blueprint for transforming prevention, care, education, and research. J Pain Pall Care Phmaracotherapy 26:197–198
Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R (2003) Lost productive time and cost due to common pain conditions in the US workforce. JAMA 290:2443–2454. doi:10.1001/jama.290.18.2443
Merskey H, Bogduk N (1994) Classification of chronic pain, 2nd edn. IASP Press, Seattle
Merskey H, Harold E (1986) Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Pain 3:S1–226
Woolf CJ, Doubell TP (1994) The pathophysiology of chronic pain—increased sensitivity to low threshold A beta-fibre inputs. Curr Opin Neurobiol 4:525–534
Zimmermann M (2001) Pathobiology of neuropathic pain. Eur J Pharmacol 429:23–37
Ji RR, Kohno T, Moore KA, Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26:696–705. doi:10.1016/j.tins.2003.09.017
Freynhagen R, Bennett MI (2009) Diagnosis and management of neuropathic pain. BMJ 339:b3002. doi:10.1136/bmj.b3002
Allegrante JP (1996) The role of adjunctive therapy in the management of chronic nonmalignant pain. Am J Med 101:33S–39S
Maurer D (1974) Transcutaneous stimulator and stimulation method. Google Patents.
Cruccu G, Aziz TZ, Garcia-Larrea L, Hansson P, Jensen TS, Lefaucheur JP, Simpson BA, Taylor RS (2007) EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 14:952–970. doi:10.1111/j.1468-1331.2007.01916.x
Nnoaham KE, Kumbang J (2008) Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev:CD003222. doi:10.1002/14651858.CD003222.pub2
Marineo G (2003) Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP 4:1–10
Deer TR, Mekhail N, Provenzano D, Pope J, Krames E, Leong M, Levy RM, Abejon D, Buchser E, Burton A, Buvanendran A, Candido K, Caraway D, Cousins M, DeJongste M, Diwan S, Eldabe S, Gatzinsky K, Foreman RD, Hayek S, Kim P, Kinfe T, Kloth D, Kumar K, Rizvi S, Lad SP, Liem L, Linderoth B, Mackey S, McDowell G, McRoberts P, Poree L, Prager J, Raso L, Rauck R, Russo M, Simpson B, Slavin K, Staats P, Stanton-Hicks M, Verrills P, Wellington J, Williams K, North R (2014) The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee. Neuromodulation 17:515–550. doi:10.1111/ner.12208
Abdi S, Lakkimsetty VM, Barrera J, Candiotti K, Lubarsky D (2011) The Use of “Scrambler Therapy” for Failed Back Surgery Syndrome. Pain Physician 14:E465–E491
Campbell T, Nimunkar AJ, Retseck J, Eickhoff JC, Backonja M, Cleary JF, Kwekkeboom KL, Yen TY (2013) A randomized, double-blind study of “Scrambler” therapy versus sham for painful chemotherapy-induced peripheral neuropathy (CIPN). J Clin Oncol 31:suppl; abstr 9635.
Coyne PJ, Wan W, Dodson P, Swainey C, Smith TJ (2013) A Trial of Scrambler Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy. J Pain Palliat Care Pharmacother 27:359–364. doi:10.3109/15360288.2013.847519
Ghatak RK, Nandi SN, Bhakta A, Mandal GC, Bandyopadhyay M, Kumar S (2011) Prospective study of application of biological communication (cybernatics) in management of chronic low back pain—a preliminary report. Nepal Med Coll J 13:257–260
Ko YK, Lee HY, Lee WY (2013) Clinical experiences on the effect of scrambler therapy for patients with postherpetic neuralgia. Korean J Pain 26:98–101. doi:10.3344/kjp.2013.26.1.98
Marineo G, Iorno V, Gandini C, Moschini V, Smith TJ (2011) Scrambler Therapy May Relieve Chronic Neuropathic Pain More Effectively Than Guideline-Based Drug Management: Results of a Pilot, Randomized, Controlled Trial. J Pain Symptom Manage 43:87–95. doi:10.1016/j.jpainsymman.2011.03.015
Moon JY, Kurihara C, Beckles JP, Williams KE, Jamison DE, Cohen SP (2014) Predictive factors associated with success and failure for calmare (Scrambler) therapy: a multi-center analysis. Clin J Pain 31:750–756. doi:10.1097/AJP.0000000000000155
Pachman DR, Weisbrod BL, Seisler DK, Barton DL, Fee-Schroeder KC, Smith TJ, Lachance DH, Liu H, Shelerud RA, Cheville AL, Loprinzi CL (2014) Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy. Support Care Cancer 23:943–951. doi:10.1007/s00520-014-2424-8
Park HS, Sin WK, Kim HY, Moon JY, Park SY, Kim YC, Lee SC (2013) Scrambler therapy for patients with cancer pain - case series. Korean J Pain 26:65–71. doi:10.3344/kjp.2013.26.1.65
Sabato AF, Marineo G, Gatti A (2005) Scrambler therapy. Minerva Anestesiol 71:479–482
Smith TJ, Marineo G (2013) Treatment of postherpetic pain with scrambler therapy, a patient-specific neurocutaneous electrical stimulation device. Am J Hosp Palliat Care. doi:10.1177/1049909113494002
Sparadeo F, Kaufman C, D’Amato S (2014) Scrambler Therapy: Effective use of artificial neurons for the treatment of neuropathic pain. J Life Care Plan 14(4):19–30
Sparadeo FCK, D’Amato S (2012) Scrambler Therapy: An Innovative and Effective Treatment for Chronic Neuropathic Pain. J Life Care Plan 11(3):3–15
Ricci M, Pirotti S, Scarpi E, Burgio M, Maltoni M, Sansoni E, Amadori D (2011) Managing chronic pain: results from an open-label study using MC5-A Calmare(R) device. Support Care Cancer 20:405–412. doi:10.1007/s00520-011-1128-6
Starkweather AR, Coyne P, Lyon DE, Elswick RK Jr, An K, Sturgill J (2015) Decreased low back pain intensity and differential gene expression following calmare(R): results from a double-blinded randomized sham-controlled study. Res Nurs Health 38:29–38. doi:10.1002/nur.21632
Smith TJ, Coyne PJ, Parker GL, Dodson P, Ramakrishnan V (2010) Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare(R)) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage 40:883–891. doi:10.1016/j.jpainsymman.2010.03.022
Notaro P, Dell’Agnola CA, Dell’Agnola AJ, Amatu A, Bencardino KB, Siena S (2015) Pilot evaluation of scrambler therapy for pain induced by bone and visceral metastases and refractory to standard therapies. Support Care Cancer. doi:10.1007/s00520-015-2952-x
Lee SC, Park KS, Moon JY, Kim EJ, Kim YC, Seo H, Kyung J, Lee DJ (2016) An exploratory study on the effectiveness of “Calmare therapy” in patients with cancer-related neuropathic pain: A pilot study. Eur J Oncol Nurs 21:1–7
Compagnone C, Tagliaferri F (2015) Chronic pain treatment and scrambler therapy: a multicenter retrospective analysis. Acta Biomed 86:149–156
Gustin SM, Peck CC, Wilcox SL, Nash PG, Murray GM, Henderson LA (2011) Different pain, different brain: thalamic anatomy in neuropathic and non-neuropathic chronic pain syndromes. J Neurosci 31:5956–5964. doi:10.1523/JNEUROSCI.5980-10.2011
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Potential conflict of interest: Competitive Technologies provided Scrambler devices and supplies to Mayo Clinic, Virginia Commonwealth University, and Johns Hopkins for conducting research.
Financial support
Research reported in the publication was supported, in part, by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers UL1TR000135 and KL2TR000136-09 (Ruddy). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Rights and permissions
About this article
Cite this article
Majithia, N., Smith, T.J., Coyne, P.J. et al. Scrambler Therapy for the management of chronic pain. Support Care Cancer 24, 2807–2814 (2016). https://doi.org/10.1007/s00520-016-3177-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3177-3